Skip to content
HowShorted

Tectonic Therapeutic, Inc. short interest in 2025

In 2025, Tectonic Therapeutic, Inc.'s disclosed short interest ran from 4.48% of shares outstanding on 15 Jan 2025 to 19.98% on 31 Dec 2025, a change of +15.50 percentage points. The year's high was 28.60% on 15 Dec 2025 and its low 4.48% on 15 Jan 2025, averaging 12.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.15 days on 15 Dec 2025. Full history: Tectonic Therapeutic, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tectonic Therapeutic, Inc. in 2025

2025 in figures

Start of year
4.48% (15 Jan 2025)
End of year
19.98% (31 Dec 2025)
Change
+15.50 pp
High
28.60% (15 Dec 2025)
Low
4.48% (15 Jan 2025)
Average
12.67%
Highest days to cover
21.15 (15 Dec 2025)
SEC filings marked
8

Every report in 2025

Tectonic Therapeutic, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20254.48%5.94
31 Jan 20257.20%1.34
14 Feb 20256.02%2.24
28 Feb 20256.40%3.58
14 Mar 20254.73%4.72
31 Mar 20255.92%3.9210-K filed, results (8-K)
15 Apr 20258.08%6.25
30 Apr 20256.44%5.95
15 May 20256.87%7.3010-Q filed, results (8-K)
30 May 20256.79%7.73
13 Jun 20257.19%8.47
30 Jun 20259.38%5.25
15 Jul 202510.30%9.85
31 Jul 202511.64%11.32
15 Aug 202513.43%9.9710-Q filed, results (8-K)
29 Aug 202513.82%20.89
15 Sep 202512.92%2.98
30 Sep 202515.23%5.02
15 Oct 202518.99%7.39
31 Oct 202525.78%6.36
14 Nov 202526.74%9.5610-Q filed, results (8-K)
28 Nov 202527.19%14.54
15 Dec 202528.60%21.15
31 Dec 202519.98%9.72

See also: Tectonic Therapeutic, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.